SEC Filing Summary: Blackboxstocks Inc. (BLBX)
Business Context and Reporting Period
This Form 8-K was filed by Blackboxstocks Inc. on October 26, 2022, reporting an event that occurred on October 25, 2022. The Company is incorporated in Nevada and its common stock trades on The Nasdaq Capital Market under the symbol "BLBX".
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for these metrics.
Material Changes
The Company received a notification from Nasdaq stating it is not in compliance with the minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)). The deficiency is based on the closing bid price of the Company's common stock remaining below $1.00 per share for 30 consecutive business days prior to the notification date.
Outlook, Risks, and Management Commentary
- Compliance Period: The Company has 180 calendar days, until April 24, 2023, to regain compliance.
- Requirement to Cure: To regain compliance, the closing bid price must be at least $1.00 per share for a minimum of 10 consecutive business days.
- Delisting Risk: If compliance is not achieved by the deadline, the Company may be eligible for an additional 180-day period if it meets other listing standards. Failure to qualify for or meet the second period will result in a delisting determination, which the Company may appeal.
- Management Action: The Company intends to monitor the stock price and may consider implementing a reverse stock split to regain compliance.
- Current Status: The notification has no immediate effect on the listing or trading of the Company's common stock.
Key Facts for Investor Verification
- Verify the current closing bid price of BLBX to assess proximity to the $1.00 threshold.
- Monitor official announcements regarding the potential implementation of a reverse stock split.
- Track the Company's progress toward the April 24, 2023, compliance deadline.
- Review subsequent filings for updates on the delisting appeal process if the initial cure period expires without compliance.